Craft
Personalis

Personalis

Facilities Leased (US), square feet

46 K

FY, 2021

Revenue

$85.5 M

FY, 2021

Market Capitalization

$137.9 M

2022-09-22

Personalis Summary

Company summary

Overview
Personalis operates as a cancer genomics company. It provides sequencing and data analysis services to support the development of cancer therapies. It also offers NeXT platform that provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics.
Type
Public
Founded
2011
HQ
Menlo Park, CA, US | view all locations
Website
https://www.personalis.com
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • John West

    John West, Chief Executive Officer

  • Richard Chen

    Richard Chen, Senior Vice President Research and Development, and Chief Medical Officer

  • Aaron Tachibana

    Aaron Tachibana, Senior Vice President and Chief Financial Officer

  • Susan Moriconi

    Susan Moriconi, Vice President of People and Chief Human Resources Officer

    Operating MetricsView all

    Patents Issued

    16
    23.1%

    FY, 2021

    Facilities Leased (US), square feet

    46K
    47.1%

    FY, 2021

    LocationsView all

    3 locations detected

    • Menlo Park, CA HQ

      United States

      1330 O'Brien Dr

    • Shanghai, Shanghai Shi

      China

      1 Chengbei Rd, Jiading Qu

    • West Wickham

      United Kingdom

      Squires House, 205A High Street

    Personalis Financials

    Summary financials

    Revenue (Q2, 2022)
    $18.2M
    Gross profit (Q2, 2022)
    $4.3M
    Net income (Q2, 2022)
    ($27.5M)
    Cash (Q2, 2022)
    $86.7M
    EBIT (Q2, 2022)
    ($27.9M)
    Enterprise value
    $103.0M

    Footer menu